TOBI COEN: Open Payments
NPI 1487346037 · HALIFAX, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,485 in 128 payments from 27 companies in 2025. Trend: 2023 $465 · 2024 $2,251 · 2025 $2,485
Food & beverage: $2,485
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $408 |
| Novo Nordisk Inc | 17 | $310 |
| Otsuka America Pharmaceutical, Inc. | 14 | $260 |
| AstraZeneca Pharmaceuticals LP | 12 | $225 |
| Lilly USA, LLC | 9 | $169 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $135 |
| Teva Pharmaceuticals USA, Inc. | 6 | $113 |
| PFIZER INC. | 5 | $89 |
| Exact Sciences Corporation | 5 | $80 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
Products named: QULIPTA, REXULTI, Wegovy, AIRSUPRA, Kerendia, AUSTEDO XR, ELIQUIS, MOUNJARO.
Industry payments across PA — which companies pay providers there.
